Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Essentially, Ozempic and Wegovy are brand names for semaglutide, which is in the GLP-1 receptor agonist (GLP-1RA) drug class.

Here is what can happen to the body once you finish a course of Ozempic as a simulation reveals what the diabetes drug does ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

While they share similarities, there are differences, particularly between the drugs semaglutide and tirzepatide.

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

Among the firms filing cases are Weitz & Luxemberg, Motley Rice, Seeger Weiss and Anapol Weiss. Novo Nordisk, in response, ...

Once boasting up to five million subscribers and being backed by the likes of Oprah Winfrey, the company is now trying to ...

Shares in Novo Nordisk were still up after Q1 2025 witnessed a total revenue jump by 18%, compared to Q1 2024.

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...

Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...